Pandemic byline in Hospital & Healthcare
What would happen in the event of a deadly new strain of influenza? Dr. Jack Regan discusses the importance of open-access diagnostics in pandemic prevention. Read his byline in Hospital & Healthcare Management.
LexaGene was featured recently in Cleanroom Technology where we spoke about LexaGene’s mission to make it as simple and easy as possible for people to detect pathogens.
Medgadget talks to CEO Dr. Jack Regan about LexaGene’s LX6 Rapid Pathogen Detection System.
Food Quality and Safety byline
Much needed innovation in food safety testing is within sight . . . Read Dr. Jack Regan’s byline in Food Quality and Safety.
Food Quality News
CEO Jack Regan discusses LexaGene’s approach to food safety and plans over the next 6-10 months in Food Quality News.
LexaGene in Food Engineering News
Food industry news magazine Food Engineering featured LexaGene in a recent article, interviewing Dr. Jack Regan about LexaGene’s rapid-testing technology.
USA Weekly profile
Dr. Jack Regan discusses LexaGene, his passion for the company, the biggest business challenge, and what advice he would give his younger self in this profile in USA Weekly.
Roundtable: Frontline Genomics
LexaGene’s CEO Jack Regan was featured in a roundtable for Frontline Genomics Magazine on infectious disease control.
Jack quoted on Inc.com
LexaGene founder and CEO Jack Regan was featured on leading business site Inc.com, where he shares his wisdom about daily habits for success.
LexaGene on The Street
Investment news outlet, The Street, speaks to LexaGene about its revolutionary pathogen detection system, and the company’s plans after the end of November 2017 when phase IV is completed.
LexaGene on FOX Biz TV
LexaGene was featured on Innovations with Ed Begley Jr. which aired on Fox Business Network 8/26 and 9/9, 2017. Learn more about LexaGene by watching the segment.
LexaGene on GenomeWeb
This GenomeWeb article, titled “LexaGene Aims for Food Safety, Veterinary Dx Markets with Microfluidic PCR Technology,” details LexaGene’s pathogen detection technology and highlights the ease of use of the technology, with a faster turnaround compared with current methods.